ArisGlobal

Overview

ArisGlobal is a life-sciences software vendor centered on pharmacovigilance, safety, regulatory, quality, and medical-affairs workflows. The core platform is LifeSphere, with LifeSphere Safety / MultiVigilance anchoring case intake, case processing, reporting, signal detection, medical coding, and global safety workflow standardization.

For a manufacturer, ArisGlobal belongs in the same decision set as Oracle Argus and Veeva Vault Safety. Oracle brings legacy installed-base gravity; Veeva brings a broader R&D cloud suite; ArisGlobal is the specialist modernization option when safety operations, AI-enabled case processing, and regulatory workflow depth matter more than buying a single broad life-sciences operating suite.

Regulatory Compliance Capability Model

The framework below standardizes how Rx Almanac evaluates regulatory-compliance capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, ArisGlobal is evaluated as life-sciences software vendor centered on pharmacovigilance, safety, regulatory, quality, and medical-affairs workflows.

Capability	Buyer should compare	ArisGlobal readout
Regulatory strategy and submissions	Submission planning, agency interactions, labeling strategy, variations, lifecycle management, and global filing support.	Not the main buying reason for ArisGlobal; validate only if the SOW includes regulatory strategy and submissions.
Pharmacovigilance and safety operations	ICSR intake, case processing, signal detection, aggregate reports, REMS/safety support, and safety databases.	major strength through LifeSphere Safety and MultiVigilance. This is the first diligence lane. Strong AI-forward posture through NavaX, MedDRA Coding Agent, Advanced Intake, Literature Intelligence, and Advanced Signals. NavaX Translation and the TransPerfect Life Sciences partnership directly target safety case translation workflow friction.
Quality systems and compliance auditing	GxP quality systems, SOPs, audits, inspection readiness, CAPA, vendor oversight, and training.	Not the main buying reason for ArisGlobal; validate only if the SOW includes quality systems and compliance auditing.
Labeling, promotional review, and medical/legal support	Label operations, MLR review, promotional compliance, medical information, and claims substantiation.	Useful for buyers that want safety / regulatory / quality harmonization without moving fully to a broader suite.
Licensing, accreditation, and specialized counsel	Pharmacy, PBM, state licensing, accreditation, healthcare law, and niche regulatory counsel.	Not the main buying reason for ArisGlobal; validate only if the SOW includes licensing, accreditation, and specialized counsel.
Technology, workflow, and reporting infrastructure	Validated systems, regulatory information management, safety platforms, dashboards, and workflow automation.	Relevant adjacent module set; validate depth against Veeva, Ennov, and specialist RIM tools. XDI is the current strategic product story; diligence should focus on production use, integrations, and governance.

Buyer Fit

• Best shortlist motion: Include ArisGlobal when the manufacturer is modernizing pharmacovigilance infrastructure, replacing legacy safety systems, or adding AI-enabled safety automation.
• Best manufacturer profile: Global pharma, midsize biotech, CROs, and health authorities with meaningful case volume, multi-country reporting, or regulatory workflow complexity.
• Where it is less direct: ArisGlobal is not a hub, specialty pharmacy, copay, or field-force vendor; its value is R&D compliance infrastructure.
• Commercial fit: Expect a platform selection and implementation program with validation, migration, integrations, operating-model design, training, and post-go-live support.

Differentiators

• Safety-native depth: ArisGlobal is built around pharmacovigilance rather than treating safety as a small module attached to a commercial platform.
• AI in production workflows: NavaX, MedDRA Coding Agent, XDI, and NavaX Translation give buyers concrete AI-enabled workflow areas to diligence.
• Global safety footprint: LifeSphere is positioned for multi-country reporting, affiliate coordination, and regulated case processing at enterprise scale.
• Specialist alternative to suite vendors: ArisGlobal is useful when buyers want more focus than a broad R&D cloud but more platform depth than a service-led pharmacovigilance outsourcer.
• Current customer momentum: 2025-2026 company materials show continued LifeSphere, NavaX, and global go-live activity.

RFP Questions

• Which LifeSphere modules are in scope: Safety, MultiVigilance, Advanced Intake, Literature Intelligence, Advanced Signals, Regulatory, Quality, Medical Affairs, NavaX, XDI, or Translation?
• What validated migration path is available from Oracle Argus, Veeva Vault Safety, or an internally maintained safety database?
• Which safety workflows are automated, which require human review, and how are AI outputs audited and overridden?
• How are MedDRA coding, duplicate detection, translation, literature review, and signal detection governed across countries and affiliates?
• What integration work is required with clinical, regulatory, quality, data-lake, document-management, and reporting systems?
• What service levels, validation artifacts, release controls, and customer-success resources are included after go-live?

Recent Activity

• 2026: ArisGlobal announced XDI, NavaX Data Intelligence, three new agents, and NavaX Translation for PV intake workflows.
• 2026: ArisGlobal launched NavaX Translation with TransPerfect Life Sciences to embed pharma-grade multilingual processing in LifeSphere Safety workflows.
• 2026: ArisGlobal reported Q1 momentum around NavaX adoption, customer wins, and enterprise AI transformation.
• 2025: Frost & Sullivan recognized ArisGlobal’s MedDRA Coding Agent for intelligent MedDRA coding innovation.
• 2025: EPS Corporation selected LifeSphere MultiVigilance for pharmacovigilance case processing, and Nippon Shinyaku selected LifeSphere Safety.